锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01951 锦欣生殖

已收盘 08-12 16:08:08

2.115

-0.025

-1.17%

最高2.150	最低2.100	成交量1,262万
今开2.150	昨收2.140	日振幅2.34%
总市值57.21亿	流通市值57.21亿	总股本27.05亿
成交额2,667万	换手率0.47%	流通股本27.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01951","market":"HK","secType":"STK","nameCN":"锦欣生殖","latestPrice":2.115,"timestamp":1786522088005,"preClose":2.14,"halted":0,"volume":12624500,"delay":0,"changeRate":-0.011682242990654164,"floatShares":2705000000,"shares":2705000000,"eps":-0.41885022835350066,"marketStatus":"已收盘","change":-0.025,"latestTime":"08-12 16:08:08","open":2.15,"high":2.15,"low":2.1,"amount":26666176,"amplitude":0.023364,"askPrice":2.115,"askSize":62500,"bidPrice":2.11,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.41885022835350066,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786584600000},"marketStatusCode":5,"adr":0,"listingDate":1561392000000,"exchange":"SEHK","adjPreClose":2.14,"dividendRate":0.020064,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"volumeRatio":1.27267,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01951","defaultTab":"news","newsList":[{"id":"1191343714","title":"锦欣生殖（01951）拟于2026年8月21日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1191343714","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191343714?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:36","pubTimestamp":1786091764,"startTime":"0","endTime":"0","summary":"锦欣生殖（01951）7日公告，公司董事会已排定于2026年8月21日（星期五）召开会议，届时将审议及批准本集团截至2026年6月30日止六个月的中期业绩并进行相关发布。  \n   \n根据公告，出席本次董事会的成员包括：执行董事董阳先生、吕蓉博士、耿丽红博士；主席兼非执行董事钟勇先生；非执行董事胡喆女士、严晓晴女士、陈树云先生；以及独立非执行董事庄一强博士、李建伟博士、王啸波先生和叶长青先生。  \n   \n公告同时显示，董阳先生现任首席执行官、代理首席财务官兼执行董事，并代表董事会发布了本次公告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553643","title":"国内首个辅助生殖诊疗AI智能体上线：锦欣生殖(01951)推出自研“IVF领航员”","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553643","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656553643?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:38","pubTimestamp":1785843528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，由锦欣生殖旗下成都锦欣信息科技有限公司自主研发的“IVF领航员”系统，在四川锦欣西囡妇女儿童医院启动试点。“IVF领航员”面向辅助生殖诊疗全流程，当前聚焦 IVF促排方案及启动用药的辅助评估。这是辅助生殖领域首个面向医生的临床辅助 AI 智能体。辅助生殖诊疗是一条连续、动态且高度个体化的临床路径。锦欣科技研发负责人王伟鹏表示。《各国辅助生殖报告2026》显示，中国头部平台的成功率位居世界前列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4082","IVF","159819","01951","BK1583","BK1597","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125745169","title":"锦欣生殖2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125745169","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125745169?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:31","pubTimestamp":1785835884,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年8月4日发布的2026年7月股份变动月报表显示，截至7月31日，公司注册股本为5,000,000,000股普通股，面值每股0.00001美元，注册资本保持在50,000美元，较上月无变化。报告期末，公司已发行股份2,705,044,043股，暂无库藏股，与上月底持平。本月未完成任何新股发行或库藏股事件。该部分股份截至报告期末尚未注销，因此公司总股本维持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654458022","title":"【券商聚焦】交银国际：下半年医药板块有望迎来修复 但内部分化或持续加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2654458022","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654458022?lang=zh_cn&edition=full","pubTime":"2026-07-28 10:01","pubTimestamp":1785204072,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，近一个月恒生医疗保健指数涨17.4%，跑赢大市。其中，生物药、CXO及处方药板块表现较优于其他板块。机构持仓方面，2026年年中以来，内资持仓延续提升态势，而外资则略有降低。该机构指，中报季临近，7月以来多家公司业绩预告陆续发布，CXO板块表现亮眼，业绩和订单延续高增长态势。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986903","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","01530","01276","LU0196878994.USD","06078","02268","LU0417516571.SGD","LU1720050803.USD","06821","BK1521","03329","KCE","03759","KURE","159938","01548","02273","LU0572944931.SGD","LU0588546209.SGD","02269","01952","03692","09926","LU0634319403.HKD","01801","01093","BK1219","LU0856984785.SGD","HK0000320223.HKD","09996","LU1813983027.USD","02162","LU2039709279.SGD","LU1880383366.USD","LU2097828714.EUR","BK1587","09939","LU2476274308.USD","HK0000165453.HKD","LU0348783233.USD","01951","09966","00013","02596","02096","LU2399975544.HKD","06996","LU2328871848.SGD","01177","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653770618","title":"【券商聚焦】交银国际维持锦欣生殖(01951)买入评级 指2Q26经营数据延续强势复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2653770618","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653770618?lang=zh_cn&edition=full","pubTime":"2026-07-24 09:32","pubTimestamp":1784856773,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，锦欣生殖 预计1H26净利润/EBITDA分别不少于0.9亿/2.9亿元，较1H25均实现扭亏；经调整净利润/经调整EBITDA同比分别+45.8%/+33.5%。1H26不孕初诊数和取卵周期数分别同比+9.1%/+6.1%，2Q26增速复苏至13.4%/8.3%。2）大湾区：不孕初诊数显著增长30.1%，2Q26初诊数大幅增长43%，该机构预计新院区运营爬坡有望驱动2H26周期数较快增长。如该机构此前预计，公司业绩和经营数据在1H26进入复苏通道，且有逐季强化的态势。维持3.1港元目标价和买入评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986664","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653140746","title":"新华健康丨改革措施逐步见效 锦欣生殖上半年扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2653140746","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653140746?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:59","pubTimestamp":1784800770,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司（证券简称“锦欣生殖”，01951.HK）近日发布的业绩预告显示，2026年上半年公司净利润预计不低于9000万元（人民币，下同），税息折旧及摊销前利润（EBITDA）不低于2.90亿元，实现扭亏为盈。锦欣生殖是一家科技驱动的辅助生殖服务商，是辅助生殖领域的龙头企业，2019年在香港上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233819035630.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233819035630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1597","BK1219","BK1583","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653081735","title":"“试管婴儿第一股”锦欣生殖：上半年扭亏为盈，不孕初诊数同比增长9.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653081735","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653081735?lang=zh_cn&edition=full","pubTime":"2026-07-22 12:24","pubTimestamp":1784694243,"startTime":"0","endTime":"0","summary":"红星资本局7月22日消息，7月21日晚，有“试管婴儿第一股”之称的锦欣生殖（1951.HK）发布了2026年上半年业绩预告，预计上半年净利润超9000万元，实现扭亏为盈；经调整EBITDA（息税折旧及摊销前利润）达3亿元，同比增长33.5%；经调整净利润超过1.2亿元，增幅超45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817042389.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817042389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","01951","BK1583","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653787764","title":"港股异动 | 锦欣生殖(01951)涨超4% 预期上半年将实现扭亏为盈 海外业务增长态势良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2653787764","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653787764?lang=zh_cn&edition=full","pubTime":"2026-07-22 10:19","pubTimestamp":1784686780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，锦欣生殖涨超4%，截至发稿，涨4.19%，报2.24港元，成交额1132.67万港元。消息面上，锦欣生殖发盈喜，预期今年上半年集团将实现扭亏为盈，期内利润不少于人民币9000万元。与此同时，锦欣生殖公布，2026年上半年的不孕症新患者就诊人次为24,169人次，较2025年同期增长9.1%。按区域划分业务表现来看，海外业务增长态势良好，取卵周期数创历史新高，同比增长42.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01951","VXUS","BK1219","KCAI","BK1583","BK4588","BK4585","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124837541","title":"锦欣生殖(01951)披露2026年上半年主要营运数据：不孕初诊人次同比增9.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124837541","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124837541?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:41","pubTimestamp":1784644906,"startTime":"0","endTime":"0","summary":"2026年7月21日，锦欣生殖公告2026年1月1日至6月30日期间的主要营运数据。公告显示，期内集团不孕症新患者就诊人次为24,169，同比增长9.1%；取卵周期数为14,653，同比增长6.1%。深圳中山妇产医院新院区投运带动大湾区不孕初诊人次增加30.1%。海外业务表现强劲，取卵周期数创历史新高，同比增幅达42.4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653077205","title":"锦欣生殖(01951.HK)上半年不孕初诊数同比增长9.1% 取卵周期数同比增长6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653077205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653077205?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:40","pubTimestamp":1784644831,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1219","01951","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206943","title":"锦欣生殖：2026年上半年不孕初诊数同比增长9.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206943","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653206943?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:40","pubTimestamp":1784644800,"startTime":"0","endTime":"0","summary":"锦欣生殖：2026年上半年不孕初诊数同比增长9.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607213816017770.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607213816017770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01951","BK1219","BK1583","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653339206","title":"锦欣生殖(01951)发盈喜 预计上半年利润不少于9000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653339206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653339206?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:39","pubTimestamp":1784644763,"startTime":"0","endTime":"0","summary":"经调整EBITDA及经调整净利润均有所增加，乃主要得益于：集团美国业务持续恢复，取卵周期数增加;集团持续拓展个性化服务，带动VIP客户渗透率提升;中国地区辅助生殖服务进一步推广普及，带动不孕症新患者就诊人次整体增加。公司由净亏损转为取得净利润及由负EBITDA转为正EBITDA，主要由于期内并无发生2025年上半年确认的重大减值亏损及其他一次性项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1219","01951","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124571712","title":"锦欣生殖(01951)发布正面盈利预告，预计2026年上半年扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1124571712","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124571712?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:36","pubTimestamp":1784644592,"startTime":"0","endTime":"0","summary":"锦欣生殖医療集團有限公司7月21日发布盈利预告，基于对截至2026年6月30日止六个月的未經審核綜合管理賬目初步評估，公司预计期内实现扭亏为盈。锦欣生殖透露，其2026年上半年中期业绩仍在编制中，相关数据尚未经过核数师或董事会下属审核及风险管理委员会审阅，最终业绩公告预计将于2026年8月底前发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184512612","title":"锦欣生殖集团 - 预期将扭亏为盈，得益于美国等市场业务持续复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=1184512612","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184512612?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:35","pubTimestamp":1784644509,"startTime":"0","endTime":"0","summary":"锦欣生殖集团预计将迎来业绩转折，实现扭亏为盈。这一积极预期主要源于集团在美国及其他市场的业务展现出持续的复苏势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","01951","BK1597","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170527538","title":"锦欣生殖更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1170527538","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170527538?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:53","pubTimestamp":1783328021,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年7月6日公布截至2026年6月30日的股份变动月报表。报告期内，法定注册股本保持在5,000,000,000股，每股面值美元0.00001，总额为美元50,000，未发生变动。公司期间未新增发行股份，也未注销或转让任何库存股。另据月报，期内未出现行使或授予新的期权。公司声明已遵守香港联交所《上市规则》及相关法律规定，确认截至本月末公众持股量符合要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134915439","title":"锦欣生殖：7月3日回购212.75万股，涉资约444.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134915439","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134915439?lang=zh_cn&edition=full","pubTime":"2026-07-03 19:23","pubTimestamp":1783077785,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司于2026年7月3日发布翌日披露报表，公告7月3日通过香港联交所场内回购212.75万股普通股，占当日公司已发行股本的0.08%。本次回购价介乎每股2.03港元至2.11港元，累计耗资约444.99万港元。根据公告显示，公司于2026年6月25日通过相关回购授权，允许最多回购26,251.20万股，迄今累计已回购853.80万股，占回购授权通过当日公司已发行股本的约0.3252%。本次公告由公司董事董阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖：7月3日回购212.75万股，涉资约444.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648663013","title":"锦欣生殖(01951.HK)7月3日斥资444.99万港元回购212.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648663013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648663013?lang=zh_cn&edition=full","pubTime":"2026-07-03 19:20","pubTimestamp":1783077611,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1597","BK1583","BK1219","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106838858","title":"锦欣生殖：7月2日回购245.05万股，耗资约493.97万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106838858","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106838858?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:02","pubTimestamp":1782990147,"startTime":"0","endTime":"0","summary":"锦欣生殖(01951)于2026年7月2日公布翌日披露报表，披露公司当日于香港联交所场内回购245.05万股普通股，占公司当日前已发行股本的0.09%，回购价格介乎每股2.00港元至2.04港元，合计耗资约493.97万港元。回购完成后，公司已发行股本总数仍为2,705,044,043股，库藏股数为0股。\n根据公告，此次回购所涉股份目前拟注销但尚未完成。在股东于2026年6月25日通过的购回授权下，公司可回购的股份总数为262,511,954股，截至本次回购后已合计在香港联交所或其他证券交易所回购6,410,500股。公司确认已遵守香港联交所证券上市规则及相关法例。公告由董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖：7月2日回购245.05万股，耗资约493.97万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501974","title":"锦欣生殖(01951.HK)7月2日耗资约493.97万港元回购245.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501974","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648501974?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:52","pubTimestamp":1782989531,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","01951","BK1597","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132166742","title":"锦欣生殖：6月30日回购396万股，耗资约779.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132166742","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132166742?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:22","pubTimestamp":1782822179,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司（01951）于2026年6月30日根据香港联交所《主板上市规则》刊发翌日披露报表，公告了当日在香港联交所场内进行股份回购的相关信息。\n当日回购普通股396万股，约占公司已发行股本0.1509%。每股回购价格介乎港币1.95元至1.98元，合计涉资约港币779.61万元。回购完成后，公司已发行股本总数仍为2,705,044,043股，且暂无库藏股份。\n本次购回股份的授权系公司于2026年6月25日通过，回购计划所对应的可回购股份总数为262,511,954股。锦欣生殖方面确认，此次回购行为已遵守香港联交所相关上市规则及适用法律法规。本公告由董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"锦欣生殖：6月30日回购396万股，耗资约779.61万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jxr-fertility.com","stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":0.0094},{"period":"3month","weight":-0.0851},{"period":"6month","weight":-0.1039},{"period":"1year","weight":-0.2664},{"period":"ytd","weight":-0.0815}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":0.0611},{"period":"3month","weight":-0.0279},{"period":"6month","weight":-0.051},{"period":"1year","weight":0.03},{"period":"ytd","weight":0.0009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"锦欣生殖医疗集团有限公司是一家投资控股公司，主要提供试管受精（IVF）服务。该公司通过其子公司主要提供辅助生殖服务、管理服务、流动手术中心设施服务、辅助医疗服务、妇产儿科医疗服务，以及从事医疗消耗品及设备销售业务。该公司主要在中国及美国提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.075902},{"month":2,"riseRate":0.714286,"avgChangeRate":0.04689},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.082478},{"month":4,"riseRate":0.571429,"avgChangeRate":0.031678},{"month":5,"riseRate":0.571429,"avgChangeRate":0.037995},{"month":6,"riseRate":0.571429,"avgChangeRate":0.015446},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023751},{"month":8,"riseRate":0.125,"avgChangeRate":-0.082134},{"month":9,"riseRate":0.285714,"avgChangeRate":0.037732},{"month":10,"riseRate":0.428571,"avgChangeRate":0.006171},{"month":11,"riseRate":0.285714,"avgChangeRate":0.08675},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.025141}],"exchange":"SEHK","name":"锦欣生殖","nameEN":"JXR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"锦欣生殖,01951,锦欣生殖股票,锦欣生殖股票老虎,锦欣生殖股票老虎国际,锦欣生殖行情,锦欣生殖股票行情,锦欣生殖股价,锦欣生殖股市,锦欣生殖股票价格,锦欣生殖股票交易,锦欣生殖股票购买,锦欣生殖股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}